Wordt geladen...
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
BACKGROUND: The oncolytic virus, coxsackievirus A21 (CVA21), has shown promise as a single agent in several clinical trials and is now being tested in combination with immune checkpoint blockade. Combination therapies offer the best chance of disease control; however, the design of successful combin...
Bewaard in:
| Gepubliceerd in: | J Immunother Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6604201/ https://ncbi.nlm.nih.gov/pubmed/31262361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0632-y |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|